Mastering NGS Assay Validation for GMP: Why It Matters for Cell and Gene Therapy

To ensure control over the development of innovative drug modalities, deploying next-generation sequencing (NGS) assays in a GMP environment is now a strategic choice of biopharma organizations. A structured validation process is essential for consistent and compliant results; however, it requires expertise, resources, and extensive project management to succeed. Genedata Selector^® streamlines this process with a fully validated, audit-ready platform that integrates multiple assays and lab systems, accelerating validation while reducing risk and future-proofing your strategy for successful cell and gene therapies.

Why Validation Is the Cornerstone of NGS Adoption

Cell and gene therapies offer transformative treatments by addressing disease at its  genetic source. However, innovation without control is a risk no manufacturer can afford. That is where NGS comes into play, offering unmatched depth for detecting contaminants, confirming vector integrity, and monitoring genome edits.

Regulatory bodies are driving this shift forward. The FDA and EMA now recognize NGS as a viable alternative to animal-based virus testing, marking a new era in quality control. Implementing NGS under Good Manufacturing Practice (GMP) is not plug-and-play. It requires a structured validation process to ensure that instruments, workflows, and software consistently deliver compliant results.

What Does NGS Validation Achieve?

Validation safeguards patient safety and lays the foundation for operational efficiency. Done right, it ensures:

• Data accuracy and reproducibility
• Traceability and integrity for every sequencing result
• Confidence that QC processes meet global standards

Where NGS Adds Value in Advanced Therapies

NGS is no longer limited to virus screening. Its applications now span:

• Identity and integrity testing for plasmids and viral vectors
• Integration site mapping for gene-modified cells
• Off-target analysis in CRISPR workflows

These capabilities make NGS indispensable for characterizing complex biological products and mitigating risks early in development.

What Does Successful Validation Look Like?

From building a compliant lab infrastructure to validating your data analysis platform, method optimization, and project coordination, NGS validation is a multi-step journey. Each decision impacts compliance, scalability, and long-term ROI.

This is where Genedata Selector comes in.
Genedata Selector provides a fully validated, GMP-ready platform designed to streamline NGS data analysis for advanced therapies. It ensures traceability, auditability, and compliance across all workflows, helping you accelerate validation while reducing risk. With built-in support for multiple assays and integration with lab systems, Genedata Selector future-proofs your strategy for evolving regulatory requirements.

Want to know the four pillars of success and how to future-proof your strategy? 

Read the full thought leadership article for expert insights and practical steps.

Key Takeaways

• NGS validation is essential for GMP compliance and patient safety.
• Hardware, software, and methods must align with stringent standards.
• Strategic planning today ensures flexibility for tomorrow’s therapies.

* This blog is adapted from an original piece published by Bioprocess International.

FAQs